A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)-Reference-Cited by-同舟云学术

A Phase II Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis From NSCLC: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)

Published:2021-12 Issue:12 Volume:16 Page:2121-2132
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Yamaguchi Hiroyuki,Wakuda Kazushige,Fukuda Minoru,Kenmotsu Hirotsugu,Mukae Hiroshi,Ito Kentaro,Chibana Kenji,Inoue Kohji,Miura Satoru,Tanaka Kentaro,Ebi Noriyuki,Suetsugu Takayuki,Harada Taishi,Kirita Keisuke,Yokoyama Toshihide,Nakatani Yuki,Yoshimura Kenichi,Nakagawa Kazuhiko,Yamamoto Nobuyuki,Sugio Kenji

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib;Omuro;Cancer,2005

2. Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer;Lee;Cancer,2010

3. Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations;Iuchi;Int J Clin Oncol,2015

4. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial;Andrews;Lancet,2004

5. Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA);Sperduto;Int J Radiat Oncol Biol Phys,2014

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Central nervous system metastases in advanced non-small cell lung cancer: A review of the therapeutic landscape;Cancer Treatment Reviews;2024-11

2. Enhancing intracranial efficacy prediction of osimertinib in non-small cell lung cancer: a novel approach through brain MRI radiomics;Frontiers in Neurology;2024-08-30

3. Complete response in a lung adenocarcinoma with pleural metastases initially treated with gefitinib and switched to osimertinib after cerebral oligo-progression with unknown T790M mutation: a case report and review of literature;Journal of Medical Case Reports;2024-08-08

4. Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET Collaboration;BMJ Open;2024-07

5. Integrated PBPK-EO modeling of osimertinib to predict plasma concentrations and intracranial EGFR engagement in patients with brain metastases;Scientific Reports;2024-06-03